CHOICE Institute Partners with Truveta for Health Research
The Comparative Health Outcomes, Policy, and Economics (CHOICE) Institute at the University of Washington’s School of Pharmacy has teamed up with Truveta to harness its electronic health record (EHR) data for essential research in health economics and outcomes. This collaboration represents a major advancement in comparative, cost-effectiveness, and outcomes research, allowing researchers to uncover vital health insights.
Accessing Extensive Real-World Data
As part of this partnership, researchers at the CHOICE Institute will utilize Truveta's vast database, which includes real-world EHR data collected from over 30 health systems across the country. This invaluable resource will enable comprehensive studies in various therapeutic areas, including diabetes, sickle cell disease, chronic pain management, and a range of public health policies.
Addressing Various Health Challenges
The research will explore the links between health policy, chronic disease management, and cognitive processes, emphasizing the importance of care in fostering healthy aging. Additional investigations will cover topics such as vaccinations, antibiotic use, care locations, patient reimbursement strategies, and health econometrics.
Employing Advanced Data Solutions
Truveta is dedicated to offering a thorough and timely database that compiles information from more than 100 million patients across 900 hospitals and 20,000 clinics. Their EHR data is frequently updated, ensuring that researchers have access to the latest information on patient care. This careful focus on data integrity allows researchers to evaluate the effectiveness of different therapies and their comparative cost efficiency for diverse population groups, including those that are often underrepresented.
Insights from the Leaders
Anirban Basu, PhD, Director at The CHOICE Institute, shared his excitement about the partnership, emphasizing its potential to drive complex research initiatives that encompass health economics and outcome evaluations. He remarked, "We are thrilled to partner with Truveta to advance our research efforts using their robust and accurate data sources."
In agreement, Truveta’s Chief Medical Officer Ryan Ahern stated, "We are proud to collaborate with The CHOICE Institute. Together, we aim to utilize real-world data to deepen our understanding of healthcare outcomes and support medical advancements that ultimately enhance patient care."
About the CHOICE Institute
The CHOICE Institute is recognized worldwide for its groundbreaking work in health research, with a mission to improve the understanding and value of medical products and services. Located within the University of Washington, the institute serves as a center for impactful health economics and outcomes research.
About Truveta
Truveta is a coalition of health systems in the U.S. committed to the mission of saving lives through data. Their regulatory-grade EHR data service offers unparalleled insights for healthcare providers and researchers, facilitating accelerated research efforts and the adoption of new treatment modalities.
Frequently Asked Questions
What is the focus of the partnership between CHOICE Institute and Truveta?
The partnership aims to utilize EHR data to enhance research in health economics, comparative effectiveness, and patient outcomes across various therapeutic areas.
How will real-world data influence healthcare research?
Real-world data provides insights into actual patient care and treatment outcomes, which can help shape healthcare policies and improve medical practices.
What therapeutic areas will be studied by the CHOICE Institute?
The CHOICE Institute plans to investigate a variety of areas, including diabetes, dementia, hepatitis C, and chronic pain management, among others.
Who is involved in this partnership?
The collaboration includes researchers from the CHOICE Institute and executives from Truveta, such as Anirban Basu and Ryan Ahern.
Why is the partnership significant?
This collaboration is significant because it merges academic research with extensive real-world data, promising to drive advancements in health outcomes and economic research.
